 | • レポートコード：MRC2-11QY11626 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病検査室イムノアッセイのグローバル市場について調査・分析したレポートです。種類別（血液検査、ブドウ糖負荷試験、糖化ヘモグロビン測定、インスリン分析、Cペプチド分析、その他）市場規模、用途別（病院、クリニック、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病検査室イムノアッセイの競争状況、市場シェア ・世界の糖尿病検査室イムノアッセイ市場：種類別市場規模 2015年-2020年（血液検査、ブドウ糖負荷試験、糖化ヘモグロビン測定、インスリン分析、Cペプチド分析、その他） ・世界の糖尿病検査室イムノアッセイ市場：種類別市場規模予測 2021年-2026年（血液検査、ブドウ糖負荷試験、糖化ヘモグロビン測定、インスリン分析、Cペプチド分析、その他） ・世界の糖尿病検査室イムノアッセイ市場：用途別市場規模 2015年-2020年（病院、クリニック、研究センター） ・世界の糖尿病検査室イムノアッセイ市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究センター） ・北米の糖尿病検査室イムノアッセイ市場分析：米国、カナダ ・ヨーロッパの糖尿病検査室イムノアッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病検査室イムノアッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病検査室イムノアッセイ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病検査室イムノアッセイ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Jei Daniel Biotech Corp.、Becton Dickenson、Acon Laboratories Inc.、Beckman Coulter Inc.、Immunoshop India Pvt Ltd.、Institute Of Isotopes Co. Ltd、Instrumentation Laboratory Co.、Abbott Diagnostics、Qqlab Llc、Quidel Corp.、Radiometer Gmbh、Roche Diagnostics Corp.、Siemens Healthcare、Sysmex、Novartis Vaccines & Diagnostics Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Diabetes Laboratory Immunoassays Market
The global Diabetes Laboratory Immunoassays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diabetes Laboratory Immunoassays Scope and Market Size
Diabetes Laboratory Immunoassays market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Laboratory Immunoassays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer AG
Jei Daniel Biotech Corp.
Becton Dickenson
Acon Laboratories Inc.
Beckman Coulter Inc.
Immunoshop India Pvt Ltd.
Institute Of Isotopes Co. Ltd
Instrumentation Laboratory Co.
Abbott Diagnostics
Qqlab Llc
Quidel Corp.
Radiometer Gmbh
Roche Diagnostics Corp.
Siemens Healthcare
Sysmex
Novartis Vaccines & Diagnostics Inc.
Market segment by Type, the product can be split into
Blood Test
Glucose Tolerance Test
Glycated Hemoglobin Determination
Insulin Assay
C Peptide Assay
Other
Market segment by Application, split into
Hospital
Clinic
Research Center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Laboratory Immunoassays Revenue
1.4 Market by Type
1.4.1 Global Diabetes Laboratory Immunoassays Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Test
1.4.3 Glucose Tolerance Test
1.4.4 Glycated Hemoglobin Determination
1.4.5 Insulin Assay
1.4.6 C Peptide Assay
1.4.7 Other
1.5 Market by Application
1.5.1 Global Diabetes Laboratory Immunoassays Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Laboratory Immunoassays Market Perspective (2015-2026)
2.2 Global Diabetes Laboratory Immunoassays Growth Trends by Regions
2.2.1 Diabetes Laboratory Immunoassays Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Laboratory Immunoassays Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Laboratory Immunoassays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Laboratory Immunoassays Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Laboratory Immunoassays Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Laboratory Immunoassays Players by Market Size
3.1.1 Global Top Diabetes Laboratory Immunoassays Players by Revenue (2015-2020)
3.1.2 Global Diabetes Laboratory Immunoassays Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Laboratory Immunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Laboratory Immunoassays Market Concentration Ratio
3.2.1 Global Diabetes Laboratory Immunoassays Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Laboratory Immunoassays Revenue in 2019
3.3 Diabetes Laboratory Immunoassays Key Players Head office and Area Served
3.4 Key Players Diabetes Laboratory Immunoassays Product Solution and Service
3.5 Date of Enter into Diabetes Laboratory Immunoassays Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetes Laboratory Immunoassays Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Laboratory Immunoassays Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
5.2 Global Diabetes Laboratory Immunoassays Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetes Laboratory Immunoassays Market Size (2015-2020)
6.2 Diabetes Laboratory Immunoassays Key Players in North America (2019-2020)
6.3 North America Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
6.4 North America Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetes Laboratory Immunoassays Market Size (2015-2020)
7.2 Diabetes Laboratory Immunoassays Key Players in Europe (2019-2020)
7.3 Europe Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
7.4 Europe Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
8 China
8.1 China Diabetes Laboratory Immunoassays Market Size (2015-2020)
8.2 Diabetes Laboratory Immunoassays Key Players in China (2019-2020)
8.3 China Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
8.4 China Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetes Laboratory Immunoassays Market Size (2015-2020)
9.2 Diabetes Laboratory Immunoassays Key Players in Japan (2019-2020)
9.3 Japan Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
9.4 Japan Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetes Laboratory Immunoassays Market Size (2015-2020)
10.2 Diabetes Laboratory Immunoassays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
11 India
11.1 India Diabetes Laboratory Immunoassays Market Size (2015-2020)
11.2 Diabetes Laboratory Immunoassays Key Players in India (2019-2020)
11.3 India Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
11.4 India Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetes Laboratory Immunoassays Market Size (2015-2020)
12.2 Diabetes Laboratory Immunoassays Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Laboratory Immunoassays Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Laboratory Immunoassays Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer AG
13.1.1 Bayer AG Company Details
13.1.2 Bayer AG Business Overview
13.1.3 Bayer AG Diabetes Laboratory Immunoassays Introduction
13.1.4 Bayer AG Revenue in Diabetes Laboratory Immunoassays Business (2015-2020))
13.1.5 Bayer AG Recent Development
13.2 Jei Daniel Biotech Corp.
13.2.1 Jei Daniel Biotech Corp. Company Details
13.2.2 Jei Daniel Biotech Corp. Business Overview
13.2.3 Jei Daniel Biotech Corp. Diabetes Laboratory Immunoassays Introduction
13.2.4 Jei Daniel Biotech Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.2.5 Jei Daniel Biotech Corp. Recent Development
13.3 Becton Dickenson
13.3.1 Becton Dickenson Company Details
13.3.2 Becton Dickenson Business Overview
13.3.3 Becton Dickenson Diabetes Laboratory Immunoassays Introduction
13.3.4 Becton Dickenson Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.3.5 Becton Dickenson Recent Development
13.4 Acon Laboratories Inc.
13.4.1 Acon Laboratories Inc. Company Details
13.4.2 Acon Laboratories Inc. Business Overview
13.4.3 Acon Laboratories Inc. Diabetes Laboratory Immunoassays Introduction
13.4.4 Acon Laboratories Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.4.5 Acon Laboratories Inc. Recent Development
13.5 Beckman Coulter Inc.
13.5.1 Beckman Coulter Inc. Company Details
13.5.2 Beckman Coulter Inc. Business Overview
13.5.3 Beckman Coulter Inc. Diabetes Laboratory Immunoassays Introduction
13.5.4 Beckman Coulter Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.5.5 Beckman Coulter Inc. Recent Development
13.6 Immunoshop India Pvt Ltd.
13.6.1 Immunoshop India Pvt Ltd. Company Details
13.6.2 Immunoshop India Pvt Ltd. Business Overview
13.6.3 Immunoshop India Pvt Ltd. Diabetes Laboratory Immunoassays Introduction
13.6.4 Immunoshop India Pvt Ltd. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.6.5 Immunoshop India Pvt Ltd. Recent Development
13.7 Institute Of Isotopes Co. Ltd
13.7.1 Institute Of Isotopes Co. Ltd Company Details
13.7.2 Institute Of Isotopes Co. Ltd Business Overview
13.7.3 Institute Of Isotopes Co. Ltd Diabetes Laboratory Immunoassays Introduction
13.7.4 Institute Of Isotopes Co. Ltd Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.7.5 Institute Of Isotopes Co. Ltd Recent Development
13.8 Instrumentation Laboratory Co.
13.8.1 Instrumentation Laboratory Co. Company Details
13.8.2 Instrumentation Laboratory Co. Business Overview
13.8.3 Instrumentation Laboratory Co. Diabetes Laboratory Immunoassays Introduction
13.8.4 Instrumentation Laboratory Co. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.8.5 Instrumentation Laboratory Co. Recent Development
13.9 Abbott Diagnostics
13.9.1 Abbott Diagnostics Company Details
13.9.2 Abbott Diagnostics Business Overview
13.9.3 Abbott Diagnostics Diabetes Laboratory Immunoassays Introduction
13.9.4 Abbott Diagnostics Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.9.5 Abbott Diagnostics Recent Development
13.10 Qqlab Llc
13.10.1 Qqlab Llc Company Details
13.10.2 Qqlab Llc Business Overview
13.10.3 Qqlab Llc Diabetes Laboratory Immunoassays Introduction
13.10.4 Qqlab Llc Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
13.10.5 Qqlab Llc Recent Development
13.11 Quidel Corp.
10.11.1 Quidel Corp. Company Details
10.11.2 Quidel Corp. Business Overview
10.11.3 Quidel Corp. Diabetes Laboratory Immunoassays Introduction
10.11.4 Quidel Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.11.5 Quidel Corp. Recent Development
13.12 Radiometer Gmbh
10.12.1 Radiometer Gmbh Company Details
10.12.2 Radiometer Gmbh Business Overview
10.12.3 Radiometer Gmbh Diabetes Laboratory Immunoassays Introduction
10.12.4 Radiometer Gmbh Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.12.5 Radiometer Gmbh Recent Development
13.13 Roche Diagnostics Corp.
10.13.1 Roche Diagnostics Corp. Company Details
10.13.2 Roche Diagnostics Corp. Business Overview
10.13.3 Roche Diagnostics Corp. Diabetes Laboratory Immunoassays Introduction
10.13.4 Roche Diagnostics Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.13.5 Roche Diagnostics Corp. Recent Development
13.14 Siemens Healthcare
10.14.1 Siemens Healthcare Company Details
10.14.2 Siemens Healthcare Business Overview
10.14.3 Siemens Healthcare Diabetes Laboratory Immunoassays Introduction
10.14.4 Siemens Healthcare Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.14.5 Siemens Healthcare Recent Development
13.15 Sysmex
10.15.1 Sysmex Company Details
10.15.2 Sysmex Business Overview
10.15.3 Sysmex Diabetes Laboratory Immunoassays Introduction
10.15.4 Sysmex Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.15.5 Sysmex Recent Development
13.16 Novartis Vaccines & Diagnostics Inc.
10.16.1 Novartis Vaccines & Diagnostics Inc. Company Details
10.16.2 Novartis Vaccines & Diagnostics Inc. Business Overview
10.16.3 Novartis Vaccines & Diagnostics Inc. Diabetes Laboratory Immunoassays Introduction
10.16.4 Novartis Vaccines & Diagnostics Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020)
10.16.5 Novartis Vaccines & Diagnostics Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetes Laboratory Immunoassays Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Laboratory Immunoassays Revenue
Table 3. Ranking of Global Top Diabetes Laboratory Immunoassays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Laboratory Immunoassays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Test
Table 6. Key Players of Glucose Tolerance Test
Table 7. Key Players of Glycated Hemoglobin Determination
Table 8. Key Players of Insulin Assay
Table 9. Key Players of C Peptide Assay
Table 10. Key Players of Other
Table 11. Global Diabetes Laboratory Immunoassays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Diabetes Laboratory Immunoassays Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Diabetes Laboratory Immunoassays Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Diabetes Laboratory Immunoassays Market Share by Regions (2015-2020)
Table 15. Global Diabetes Laboratory Immunoassays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Diabetes Laboratory Immunoassays Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Diabetes Laboratory Immunoassays Market Growth Strategy
Table 21. Main Points Interviewed from Key Diabetes Laboratory Immunoassays Players
Table 22. Global Diabetes Laboratory Immunoassays Revenue by Players (2015-2020) (Million US$)
Table 23. Global Diabetes Laboratory Immunoassays Market Share by Players (2015-2020)
Table 24. Global Top Diabetes Laboratory Immunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Laboratory Immunoassays as of 2019)
Table 25. Global Diabetes Laboratory Immunoassays by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Diabetes Laboratory Immunoassays Product Solution and Service
Table 28. Date of Enter into Diabetes Laboratory Immunoassays Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 31. Global Diabetes Laboratory Immunoassays Market Size Share by Type (2015-2020)
Table 32. Global Diabetes Laboratory Immunoassays Revenue Market Share by Type (2021-2026)
Table 33. Global Diabetes Laboratory Immunoassays Market Size Share by Application (2015-2020)
Table 34. Global Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 35. Global Diabetes Laboratory Immunoassays Market Size Share by Application (2021-2026)
Table 36. North America Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 38. North America Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 39. North America Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 40. North America Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 41. North America Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 42. Europe Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 44. Europe Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 46. Europe Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 48. China Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 49. China Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 50. China Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 51. China Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 52. China Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 53. China Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 54. Japan Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 56. Japan Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 58. Japan Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 62. Southeast Asia Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 64. Southeast Asia Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 66. India Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 67. India Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 68. India Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 69. India Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 70. India Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 71. India Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Diabetes Laboratory Immunoassays Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Diabetes Laboratory Immunoassays Market Share (2019-2020)
Table 74. Central & South America Diabetes Laboratory Immunoassays Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Diabetes Laboratory Immunoassays Market Share by Type (2015-2020)
Table 76. Central & South America Diabetes Laboratory Immunoassays Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Diabetes Laboratory Immunoassays Market Share by Application (2015-2020)
Table 78. Bayer AG Company Details
Table 79. Bayer AG Business Overview
Table 80. Bayer AG Product
Table 81. Bayer AG Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 82. Bayer AG Recent Development
Table 83. Jei Daniel Biotech Corp. Company Details
Table 84. Jei Daniel Biotech Corp. Business Overview
Table 85. Jei Daniel Biotech Corp. Product
Table 86. Jei Daniel Biotech Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 87. Jei Daniel Biotech Corp. Recent Development
Table 88. Becton Dickenson Company Details
Table 89. Becton Dickenson Business Overview
Table 90. Becton Dickenson Product
Table 91. Becton Dickenson Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 92. Becton Dickenson Recent Development
Table 93. Acon Laboratories Inc. Company Details
Table 94. Acon Laboratories Inc. Business Overview
Table 95. Acon Laboratories Inc. Product
Table 96. Acon Laboratories Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 97. Acon Laboratories Inc. Recent Development
Table 98. Beckman Coulter Inc. Company Details
Table 99. Beckman Coulter Inc. Business Overview
Table 100. Beckman Coulter Inc. Product
Table 101. Beckman Coulter Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 102. Beckman Coulter Inc. Recent Development
Table 103. Immunoshop India Pvt Ltd. Company Details
Table 104. Immunoshop India Pvt Ltd. Business Overview
Table 105. Immunoshop India Pvt Ltd. Product
Table 106. Immunoshop India Pvt Ltd. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 107. Immunoshop India Pvt Ltd. Recent Development
Table 108. Institute Of Isotopes Co. Ltd Company Details
Table 109. Institute Of Isotopes Co. Ltd Business Overview
Table 110. Institute Of Isotopes Co. Ltd Product
Table 111. Institute Of Isotopes Co. Ltd Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 112. Institute Of Isotopes Co. Ltd Recent Development
Table 113. Instrumentation Laboratory Co. Business Overview
Table 114. Instrumentation Laboratory Co. Product
Table 115. Instrumentation Laboratory Co. Company Details
Table 116. Instrumentation Laboratory Co. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 117. Instrumentation Laboratory Co. Recent Development
Table 118. Abbott Diagnostics Company Details
Table 119. Abbott Diagnostics Business Overview
Table 120. Abbott Diagnostics Product
Table 121. Abbott Diagnostics Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 122. Abbott Diagnostics Recent Development
Table 123. Qqlab Llc Company Details
Table 124. Qqlab Llc Business Overview
Table 125. Qqlab Llc Product
Table 126. Qqlab Llc Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 127. Qqlab Llc Recent Development
Table 128. Quidel Corp. Company Details
Table 129. Quidel Corp. Business Overview
Table 130. Quidel Corp. Product
Table 131. Quidel Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 132. Quidel Corp. Recent Development
Table 133. Radiometer Gmbh Company Details
Table 134. Radiometer Gmbh Business Overview
Table 135. Radiometer Gmbh Product
Table 136. Radiometer Gmbh Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 137. Radiometer Gmbh Recent Development
Table 138. Roche Diagnostics Corp. Company Details
Table 139. Roche Diagnostics Corp. Business Overview
Table 140. Roche Diagnostics Corp. Product
Table 141. Roche Diagnostics Corp. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 142. Roche Diagnostics Corp. Recent Development
Table 143. Siemens Healthcare Company Details
Table 144. Siemens Healthcare Business Overview
Table 145. Siemens Healthcare Product
Table 146. Siemens Healthcare Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 147. Siemens Healthcare Recent Development
Table 148. Sysmex Company Details
Table 149. Sysmex Business Overview
Table 150. Sysmex Product
Table 151. Sysmex Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 152. Sysmex Recent Development
Table 153. Novartis Vaccines & Diagnostics Inc. Company Details
Table 154. Novartis Vaccines & Diagnostics Inc. Business Overview
Table 155. Novartis Vaccines & Diagnostics Inc. Product
Table 156. Novartis Vaccines & Diagnostics Inc. Revenue in Diabetes Laboratory Immunoassays Business (2015-2020) (Million US$)
Table 157. Novartis Vaccines & Diagnostics Inc. Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Laboratory Immunoassays Market Share by Type: 2020 VS 2026
Figure 2. Blood Test Features
Figure 3. Glucose Tolerance Test Features
Figure 4. Glycated Hemoglobin Determination Features
Figure 5. Insulin Assay Features
Figure 6. C Peptide Assay Features
Figure 7. Other Features
Figure 8. Global Diabetes Laboratory Immunoassays Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Research Center Case Studies
Figure 12. Diabetes Laboratory Immunoassays Report Years Considered
Figure 13. Global Diabetes Laboratory Immunoassays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Diabetes Laboratory Immunoassays Market Share by Regions: 2020 VS 2026
Figure 15. Global Diabetes Laboratory Immunoassays Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Diabetes Laboratory Immunoassays Market Share by Players in 2019
Figure 18. Global Top Diabetes Laboratory Immunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Laboratory Immunoassays as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Laboratory Immunoassays Revenue in 2019
Figure 20. North America Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Diabetes Laboratory Immunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…- 糖尿病モニターの世界市場（～2026年） Diabetes mellitus is a chronic disease resulting from an inadequacy of insulin in the body. The condition causes either elevated blood-glucose concentrations, named as hyperglycaemia, or low glucose level known as hypoglycaemia. Monitoring glucose level is expected to prolong life expectancy as it e…
- 貧血・ビタミン検査の世界市場（～2026年） Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or lo…
- ラテラルフローイムノアッセイの世界市場（～2026年） Lateral flow immunoassays are easy to use. The user simply needs to dip the sample pad into the liquid they want to test and then lay the test flat or apply the sample directly to the cassette. If the test is positive, a colored or fluorescent line will show up on the test along with a control line.…
- 無針糖尿病治療の世界市場（～2026年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…